The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

LONDON, Dec 23 (Reuters) - Novo Nordisk's (NOVOb.CO) newly approved weight-loss pill version of Wegovy will be a test case ...

Novo Nordisk shares jumped nearly 8% on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, ...

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

The FDA has approved a pill form of the popular GLP-1 weight-loss medication Wegovy. Novo Nordisk says it is as effective as ...

The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, ...

Wegovy's new pill has been approved in the US, offering a needle-free option with a lower starting price than injections.

The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral version of the Wegovy weight loss pill, the first ...